Practice Expertise

  •  
  •  
  •  
  •  

Areas of Practice

  • Commercial Contracts
  • Corporate / M&A
  •  
  •  

WSG Practice Industries

Profile

Iliana Djagova is counsel in the Corporate/M&A team of Walder Wyss. Her practice focuses on domestic and international M&A transactions and general commercial and corporate law matters for listed and private companies.

Iliana Djagova studied law at the University of Zurich (lic. iur., 2010) and the University of California, Berkeley (LL.M., 2015). She was admitted to the Zurich Bar in 2013 and to the New York Bar in 2018. Prior to joining Walder Wyss, Iliana Djagova was working for several years at another leading Swiss law firm. In 2015/16 she worked at Willkie Farr & Gallagher LLP in New York, USA.

Iliana Djagova speaks German, English, French and Bulgarian.

Areas of Practice

  • Commercial Contracts
  • Corporate / M&A

Professional Career

Significant Accomplishments

Boehringer Ingelheim acquires veterinary therapeutic vaccines developer Saiba Animal Health

Swixx Biopharma acquires Biopas to enter Latin America

SOPHiA GENETICS SA closed secured term loan financing

Walder Wyss advised CRISPR Therapeutics (NASDAQ) on USD 280 Million Equity Issuance

Walder Wyss advised Nasdaq listed Altamira Therapeutics in its sale of majority stake in Altamira Medica





Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.